Discovery of Brain-Penetrant, Orally Bioavailable Aminothienopyridazine Inhibitors of Tau Aggregation
- 14 April 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (9), 3739-3747
- https://doi.org/10.1021/jm100138f
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathiesNature Reviews Drug Discovery, 2009
- Tau-directed drug discovery for Alzheimer's disease and related tauopathies: A focus on tau assembly inhibitorsExperimental Neurology, 2009
- Evidence that Non-Fibrillar Tau Causes Pathology Linked to Neurodegeneration and Behavioral ImpairmentsJournal of Alzheimer's Disease, 2008
- Nucleation-dependent Tau Filament FormationJournal of Biological Chemistry, 2008
- Tau-mediated neurodegeneration in Alzheimer's disease and related disordersNature Reviews Neuroscience, 2007
- Untangling tau hyperphosphorylation in drug design for neurodegenerative diseasesNature Reviews Drug Discovery, 2007
- High throughput screening for small molecule inhibitors of heparin-induced tau fibril formationBiochemical and Biophysical Research Communications, 2007
- Screening for Inhibitors of Tau PolymerizationCurrent Alzheimer Research, 2005
- Neurodegenerative TauopathiesAnnual Review of Neuroscience, 2001
- Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors.The Journal of cell biology, 1985